Mount Vernon Associates’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Sell
16,177
-1,988
-11% -$131K 0.67% 34
2026
Q1
$1.29M Buy
18,165
+144
+0.8% +$11.4K 0.91% 29
2025
Q4
$1.48M Hold
18,021
0.99% 28
2025
Q3
$1.35M Buy
18,021
+50
+0.3% +$3.73K 0.94% 28
2025
Q2
$1.33M Buy
17,971
+250
+1% +$17.4K 0.96% 27
2025
Q1
$1.43M Sell
17,721
-33
-0.2% -$2.84K 1.17% 25
2024
Q4
$1.39M Hold
17,754
1.08% 25
2024
Q3
$1.67M Buy
17,754
+634
+4% +$53.2K 1.32% 24
2024
Q2
$1.33M Sell
17,120
-600
-3% -$48.9K 1.18% 24
2024
Q1
$1.61M Hold
17,720
1.37% 24
2023
Q4
$1.37M Sell
17,720
-133
-0.7% -$9.31K 1.34% 24
2023
Q3
$1.22M Buy
17,853
+62
+0.3% +$4.51K 1.34% 24
2023
Q2
$1.45M Buy
17,791
+13,903
+358% +$1.11M 1.54% 24
2023
Q1
$319K Buy
+3,888
New +$278K 0.38% 41

Other funds holding GEHC

Mount Vernon Associates's GEHC Position: Q2 2026 in Review

Mount Vernon Associates reduced its GE HealthCare (GEHC) stake by 11% in Q2 2026, selling an estimated $131K and leaving 16,177 shares worth $1.03M. The position accounts for 0.67% of the portfolio, ranked #34.

Mount Vernon Associates first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.67M in Q3 2024. 469 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Mount Vernon Associates held 16,177 shares of GE HealthCare worth $1.03M as of Q2 2026.
  • Mount Vernon Associates sold 1,988 GE HealthCare shares in Q2 2026, an estimated $131K.
  • GE HealthCare made up 0.67% of Mount Vernon Associates's portfolio in Q2 2026, its #34 holding.
  • Mount Vernon Associates first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Mount Vernon Associates's GE HealthCare position peaked at $1.67M in Q3 2024.
  • 469 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Mount Vernon Associates's 13F filing for Q2 2026, filed 24 Jul 2026.